How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2022 · second_quarter · Q2
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Source: Senate LDA
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Quit Because of COVID–19 Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Quit Because of COVID–19 Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Safe Step Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Safe Step Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Colorectal Cancer Payment Fairness Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Colorectal Cancer Payment Fairness Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles FY22 Omnibus - NIH, NCI, CDC DCPC and OSH funding requests
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Accelerating Kids’ Access to Care Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Accelerating Kids’ Access to Care Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Incentivizing Medicaid Expansion Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Incentivizing Medicaid Expansion Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Cancer Care Planning and Communications Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Cancer Care Planning and Communications Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
DIVERSE Trials Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
DIVERSE Trials Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Inflation Reduction Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Inflation Reduction Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Inflation Reduction Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Inflation Reduction Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Gabriella Miller Kids First Research Act 2.0
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Gabriella Miller Kids First Research Act 2.0
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
CARING for Kids Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
CARING for Kids Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
To amend title 38, United States Code, to make certain improvements to the Office of Accountability and Whistleblower Protection of the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
To amend title 38, United States Code, to make certain improvements to the Office of Accountability and Whistleblower Protection of the Department of Veterans Affairs, and for other purposes.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Give Kids a Chance Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Give Kids a Chance Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Health Equity and Accountability Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Food and Drug Amendments of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
RISE Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles FY22 Omnibus - NIH, NCI, CDC DCPC and OSH funding requests
RISE Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles FY22 Omnibus - NIH, NCI, CDC DCPC and OSH funding requests
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Tobacco Tax Equity Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Lymphedema Treatment Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
CONNECT for Health Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
CONNECT for Health Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Accelerating Kids’ Access to Care Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
Accelerating Kids’ Access to Care Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
SAME Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
SAME Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Quit Because of COVID–19 Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Quit Because of COVID–19 Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
DIVERSE Trials Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
DIVERSE Trials Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
RISE Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles FY22 Omnibus - NIH, NCI, CDC DCPC and OSH funding requests
RISE Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Provider Training in Palliative Care Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Provider Training in Palliative Care Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
RARE Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Palliative Care and Hospice Education and Training Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
FDASLA Act of 2022
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Safe Step Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
Safe Step Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Women and Lung Cancer Research and Preventive Services Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Women and Lung Cancer Research and Preventive Services Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions - ACA tax credits permanency HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 S. 4260, The Palliative Care and Hospice Education and Training Act Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Surprises Act Proposed Rule on Affordability of Employer Coverage for Family Members of Employees, REG-114339-21 Regulations related to short term limited duration health insurance plans OMB RFI on health equity - comments DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972 NIH Clinical Trials Diversity Act HR 7667, Food and Drug Amendments Act Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, S 4348 S. 4185, the Retaining Access and Restoring Exclusivity (RARE) Act Potential legislation on cancer survivorship being developed by Rep. Wasserman Schultz Health Equity and Accountability Act, HR 7585
American Cures Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles FY22 Omnibus - NIH, NCI, CDC DCPC and OSH funding requests
American Cures Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
American Rescue Plan Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. HR 1319, American Rescue Plan Act of 2021
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 FY2023 OMB Letter related to CDC OSH
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon
PREVENT HPV Cancers Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon
Stabilize Medicaid and CHIP Coverage Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HRes 209, Supporting the designation of March 2021 as National Colorectal Cancer Awareness Month HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 2144, Access to Genetic Counselor Services Act HR 340, the Incentivizing Medicaid Expansion Act HR 1738, the Stabilize Medicaid and CHIP Coverage Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Discussion draft of the HCBS Access Act
Fair Indexing for Health Care Affordability Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HRes 209, Supporting the designation of March 2021 as National Colorectal Cancer Awareness Month HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 2144, Access to Genetic Counselor Services Act HR 340, the Incentivizing Medicaid Expansion Act HR 1738, the Stabilize Medicaid and CHIP Coverage Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Discussion draft of the HCBS Access Act
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
CHIPP Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Health Care Enrollment Innovation Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
MORE Health Education Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
To amend title XXVII of the Public Health Service Act to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage.
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
State Health Care Premium Reduction Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
Health Insurance Consumer Protection Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HRes 209, Supporting the designation of March 2021 as National Colorectal Cancer Awareness Month HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 2144, Access to Genetic Counselor Services Act HR 340, the Incentivizing Medicaid Expansion Act HR 1738, the Stabilize Medicaid and CHIP Coverage Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Discussion draft of the HCBS Access Act
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
WORK NOW Act
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC · Firm: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. WORK NOW Act, HR 1987, S 740 Legacy IRA Act, HR 3832, S. 243
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: Patient Navigation Assistance Act (Soon to be introduced), Rep. DeSaulnier The Build Back Better Act, HR 5376 & budget reconciliation discussions - Medicaid Coverage Gap fix, cap on out of pocket expenses for Medicare Part D HR 1946/S 1873, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089 Regulations related to the Public Charge Rule & Medicaid - DHS Docket No. USCIS-2021-0013, the notice of proposed rulemaking, Public Charge Ground of Inadmissibility Public Health Emergency Extension Advocacy around cost sharing for follow on colonoscopy after a positive at home test with CMS, related to Medicare coverage
FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Legacy IRA Act, S, 243
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2022 · first_quarter · Q1
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Legacy IRA Act, S, 243
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 DEPICT Act Give Kids a Chance Act, H.R. 6972
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles FY22 Omnibus - NIH, NCI, CDC DCPC and OSH funding requests
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen Accelerating Kids Access to Care Act, S. 1544/H.R. 3089
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2021 · fourth_quarter · Q4
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706 FY2023 OMB Letter related to CDC OSH
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. The Build Back Better Act, HR 5376 & budget reconciliation discussions
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles * DIVERSE Trials Act - H.R.5030/ S.2706 * The Build Back Better Act, HR 5376 & budget reconciliation discussions
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act FY2023 OMB Letter The Build Back Better Act, HR 5376 & budget reconciliation discussions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2021 · third_quarter · 3A
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2021 · second_quarter · 2A
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. WORK NOW Act, HR 1987, S 740 Legacy IRA Act, HR 3832, S. 243
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The Protect Act
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2021 · third_quarter · Q3
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Provider Training in Palliative Care Act, S 2890 Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon DIVERSE Trials Act - H.R.5030/ S.2706
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2021 · second_quarter · Q2
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. WORK NOW Act, HR 1987, S 740 Legacy IRA Act, HR 3832, S. 243
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The Protect Act
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2021 · first_quarter · Q1
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HRes 209, Supporting the designation of March 2021 as National Colorectal Cancer Awareness Month HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 2144, Access to Genetic Counselor Services Act HR 340, the Incentivizing Medicaid Expansion Act HR 1738, the Stabilize Medicaid and CHIP Coverage Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Discussion draft of the HCBS Access Act
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID Act
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2020 · fourth_quarter · 4A
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 6514, Worker Health Coverage Protection Act HR 1425, Patient Protection and Affordable Care Enhancement Act Issues related to regulations for implementing section 1557 of the Affordable Care Act on anti-discrimination HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act Issues related to the Senate HELP Committee initiative on preparing for future pandemics. Regulatory issues related to telehealth Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Introduction of the S. 3404 & H.R. 6102, Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing health disparities in cancer clinical trials; Issues related to capturing racial and ethnic data demographic data for communities disproportionately affected by coronavirus; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 S. 2497, the Dependent Income Exclusion Act; Issues related to HHS regulation of prescription drug prices and costs; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; H.R. 6556, the Gabriella Miller Kids First Research Act 2.0; H.R. 4439 & S. 4010, the Creating Hope Reauthorization Act; H.R.6666 & S. 4315, the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act, bill related to support needed data collection efforts to begin to contain coronavirus; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; Issues related to improving data collection during the COVID-19 pandemic; and H.Res 1125, which expresses support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics in clinical trials for therapies, diagnostics, and vaccines for COVID -19. S 4557, COVID Enrollment Response Act (Sen. Baldwin)
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2020 · fourth_quarter · 4A
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to economic relief for nonprofit organizations and charitable giving incentives included in H.R. 6408, the Saving the Organizations that Serve (SOS) America Act, H.R.3814, the Reviving the Economy Sustainably Towards A Recovery in Twenty-twenty Act or the RESTART Act, S.3747, the WORK NOW Act, S.4032 and H.R.7324, the Universal Giving Pandemic Response Act, charitable giving amendment (S.Amdt. 1566) to the CARES Act, S.4001and S.4209, the Protecting Nonprofits from Catastrophic Cash Flow Strain Act of 2020, H.R. 7066, the Reopening America by Supporting Workers and Businesses Act of 2020, the Help Charities Protect Communities Act (introduction pending), S. 178 (legislative vehicle for the Protect Act), and HR 925, The Heroes Act. Medical expense deduction - lowering the percentage to 7.5%
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2020 · fourth_quarter · Q4
FY 2021 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding of the World Health Organization and for cervical cancer screening & treatment and HPV vaccination; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 133, Consolidated Appropriations Act, 2021 HR 8337, Making continuing appropriations for fiscal year 2021, and for other purposes HR 925, the HEROES Act HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act H.R.7610, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 S 178, Legislative vehicle for the Protect Act
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2020 · third_quarter · Q3
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 6514, Worker Health Coverage Protection Act HR 1425, Patient Protection and Affordable Care Enhancement Act Issues related to regulations for implementing section 1557 of the Affordable Care Act on anti-discrimination HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act Issues related to the Senate HELP Committee initiative on preparing for future pandemics. Regulatory issues related to telehealth Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Introduction of the S. 3404 & H.R. 6102, Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing health disparities in cancer clinical trials; Issues related to capturing racial and ethnic data demographic data for communities disproportionately affected by coronavirus; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 S. 2497, the Dependent Income Exclusion Act; Issues related to HHS regulation of prescription drug prices and costs; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; H.R. 6556, the Gabriella Miller Kids First Research Act 2.0; H.R. 4439 & S. 4010, the Creating Hope Reauthorization Act; H.R.6666 & S. 4315, the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act, bill related to support needed data collection efforts to begin to contain coronavirus; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; Issues related to improving data collection during the COVID-19 pandemic; and H.Res 1125, which expresses support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics in clinical trials for therapies, diagnostics, and vaccines for COVID -19. S 4557, COVID Enrollment Response Act (Sen. Baldwin)
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2020 · second_quarter · Q2
FY 2021 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding of the World Health Organization and for cervical cancer screening & treatment and HPV vaccination; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act H.R.7610, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2020 · first_quarter · Q1
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; S. 655 and H.R.1498, Stopping Appealing Flavors in E-Cigarettes for Kids Act; S. 1048 and H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; H.R.1854 & S.9, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 2084, the Stopping Consumption of Tobacco by Teens Act of 2019; H.R. 2339 and S. 3174, Reversing the Youth Tobacco Epidemic Act; S. 1258 and H.R. 2411, Tobacco to 21 Act, and H.R. 1865, the Further consolidated Appropriations Act, 2020; Issues related to FDA tobacco control to be considered in House and Senate in the FY20 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation; H.R. 293, Youth Vaping Prevention Act of 2019; S. 616, E-Cigarette youth Protection Act; S. 1253, Preventing Online Sales of E-Cigarettes to Children Act; S. 1541, Tobacco-Free Youth Act; S. 1895, Lower Health Care Costs Act regarding tobacco 21 age of sale provisions; H.R. 1865 Further Consolidated Appropriations Act, 2020 regarding tobacco 21 age of sale provisions; S 1832, Smoke-Free Schools Act; S. 2726, Banning Smoking on Amtrak Act of 2019; Issues related to smoke-free policies for the Veterans Health Administration, H.R. 3700 and S. 2106; H.R. 4249, Stop Vaping Ads Act; S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019; S. 2519, Ending New Nicotine Dependencies Act of 2019 (ENND Act); H.R. 4624 Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2019; H.R. 5482 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; S. 3096 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; H.R. 5482 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; H.R. 5005 the Preventing Vape Use Act; Issues related to taxation of tobacco products: S. 2463, E-cigarette Tax Parity Act; S. 2517, Tobacco Tax Equity Act of 2019, and H.R. 4742, the Protecting American Lungs Act, a bill to amend the Internal Revenue Code of 1986 to impose a tax on nicotine used in e-cigarettes; and Issues related to FDAs development of its final guidance on Enforcement Priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2019 · fourth_quarter · Q4
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; S. 655 and H.R.1498, Stopping Appealing Flavors in E-Cigarettes for Kids Act; S. 1048 and H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; H.R.1854 & S.9, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 2084, the Stopping Consumption of Tobacco by Teens Act of 2019; H.R. 2339 and S. 3174, Reversing the Youth Tobacco Epidemic Act; S. 1258 and H.R. 2411, Tobacco to 21 Act, and H.R. 1865, the Further consolidated Appropriations Act, 2020; Issues related to FDA tobacco control to be considered in House and Senate in the FY20 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation; H.R. 293, Youth Vaping Prevention Act of 2019; S. 616, E-Cigarette youth Protection Act; S. 1253, Preventing Online Sales of E-Cigarettes to Children Act; S. 1541, Tobacco-Free Youth Act; S. 1895, Lower Health Care Costs Act regarding tobacco 21 age of sale provisions; H.R. 1865 Further Consolidated Appropriations Act, 2020 regarding tobacco 21 age of sale provisions; S 1832, Smoke-Free Schools Act; S. 2726, Banning Smoking on Amtrak Act of 2019; Issues related to smoke-free policies for the Veterans Health Administration, H.R. 3700 and S. 2106; H.R. 4249, Stop Vaping Ads Act; S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019; S. 2519, Ending New Nicotine Dependencies Act of 2019 (ENND Act); H.R. 4624 Ending Nicotine Dependence from Electronic Nicotine Delivery Systems Act of 2019; H.R. 5482 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; S. 3096 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; H.R. 5482 Providing Resources to End the Vaping Epidemic Now for Teenagers Act of 2020; H.R. 5005 the Preventing Vape Use Act; Issues related to taxation of tobacco products: S. 2463, E-cigarette Tax Parity Act; S. 2517, Tobacco Tax Equity Act of 2019, and H.R. 4742 a bill to amend the Internal Revenue Code of 1986 to impose a tax on nicotine used in e-cigarettes; and Issues related to FDAs development of its final guidance on Enforcement Priorities for Electronic Nicotine Delivery Systems (ENDS) and Other Deemed Products on the Market Without Premarket Authorization.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2019 · third_quarter · Q3
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law. Issues relating to FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 1948 & S. 518, the Lymphedema Treatment Act H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; and Cannabis research issues, including S. 2032. H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 HR___, Medical Records Fairness Act (Rep. Bill Foster, D-IL) S. 2497, the Dependent Income Exclusion Act SJ Res 52, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers". Issues related to prescription drug costs - H.R. 3, the Lower Prescription Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4439, Creating Hope Reauthorization Act
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2019 · second_quarter · Q2
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; S. 655 and H.R.1498, Stopping Appealing Flavors in E-Cigarettes for Kids Act; S. 1048 and H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; H.R.1854 & S.9, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 2084, the Stopping Consumption of Tobacco by Teens Act of 2019; H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019; S. 1258 and H.R. 2411, Tobacco to 21 Act; Issues related to FDA tobacco control to be considered in House and Senate in the FY20 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation; H.R. 293, Youth Vaping Prevention Act of 2019; S. 616, E-Cigarette youth Protection Act; S. 1253, Preventing Online Sales of E-Cigarettes to Children Act; S. 1541, Tobacco-Free Youth Act; S. 1895, Lower Health Care Costs Act regarding tobacco 21 age of sale provisions; S 1832, Smoke-Free Schools Act; S. 2726, Banning Smoking on Amtrak Act of 2019; and Issues related to smoke-free policies for the Veterans Health Administration, H.R. 3700 and S. 2106.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2019 · first_quarter · Q1
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, and wellness, including: HR 1010, to provide that the short-term rule has no force or effect; HR 986 & S 466, Protecting Americans with Pre-Existing Conditions Act; HR 1425, State Health Care Premium Reduction Act; HR 1386, Expand Navigators Resources for Outreach, Learning, and Longevity Act of 2019; HR 1884, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act of 2019; HR 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019; Issues relating to curbing health care costs; Issues related to surprise medical billing; H.R.647, the Palliative Care and Hospice Education and Training Act; Issues related to Breast Density and Mammography Reporting; H.R.820 & S.292, the Childhood Cancer STAR Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017; Issues relating to FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; Caregiving, including H.R. 3759/S. 1028, the RAISE Family Caregivers Act; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; and H.R. 1730 and S. 741, the Cancer Drug Parity Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2018 · first_quarter · 1A
Creating parity in taxation of tobacco products respecting S. 1837; HR1 tax bill relating to its implementation roll out and impact on charitable deductions.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2018 · fourth_quarter · Q4
Federal budget and appropriations for cancer research and programs, including: FY 2019 federal appropriations for the FDA; the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the State/Foreign Operations Appropriations Act; issues relating to global health funding for HPV vaccination and cervical cancer screening and treatment: and issues regarding future work and funding of the CDC tobacco work.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; H.R. 4122 & S. 2006, the Breast Density & Mammography Reporting Act; and H.R.820 & S.292, the Childhood Cancer STAR Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. The proposed Medical Records Fairness Act (no number yet). Issues regarding the Affordable Care Act premium tax credits and catastrophic plans, HR 6311. Issues regarding protections for people with pre-existing conditions, including S. 3388, HR 6898, and H. Res. 1066. Resolutions to disapprove the short-term rule, H.J. Res 140 and S. J. Res. 63. Advocacy against including the Association Health Plan provision of the House Farm bill in the conference report, H.R. 2 and s. 3042 (section 6004 of the House-passed version of the legislation). Issues involving patient navigation, including the Patient Navigation Assistance Act, HR 6808. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018. H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018. Issues related to caregiving, including H.R. 3759/S. 1028, the RAISE Family Caregivers Act, H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2018 · third_quarter · Q3
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control as considered in House and Senate, FY18 and The FY19 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273. Issues regarding flavors in tobacco products including e-cigarettes and cigars respecting S.3319, the SAFE Kids Act, and development of similar legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2018 · second_quarter · Q2
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2018 · first_quarter · 1A
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · 4A
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · 4A
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · 4A
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · fourth_quarter · Q4
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · third_quarter · Q3
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller-Johnson repeal bill. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · second_quarter · Q2
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the American Health Care Act and the Better Care Reconciliation Act. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2017 · first_quarter · Q1
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including the American Health Care Act. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, Removing Barriers to Colorectal Cancer Screening Act; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · fourth_quarter · 4A
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · fourth_quarter · 4A
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on issues relating to NIH and cancer moonshot funding in the context of H.R. 2028, the Continuing and Security Assistance Appropriations Act; and, H.R. 34, the 21st Century Cures Act. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · fourth_quarter · Q4
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · third_quarter · Q3
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on H.R.2577, FY17 THUD - MIL CON Appropriations legislation; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.5054, the House FY17 Agriculture Appropriations legislation and S.2956, the Senate companion Appropriations bill; S.3040, the Senate FY17 Labor, Health and Human Services Appropriations legislation and the un-numbered House companion Appropriations bill; issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation; and the House-passed 21st Century Cures legislation. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · second_quarter · Q2
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on H.R.2577, FY17 THUD - MIL CON Appropriations legislation; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.5054, the House FY17 Agriculture Appropriations legislation and S.2956, the Senate Companion Appropriations bill; S.3040, the Senate FY17 Labor, Health and Human Services Appropriations legislation and the un-numbered House Companion Appropriations bill; issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation; and the House-passed 21st Century Cures legislation. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation and the House Companion draft Appropriations bill.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · first_quarter · 1A
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in H.R.__, FY17 Agriculture Appropriations legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2016 · first_quarter · Q1
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.__, the FY17 Agriculture Appropriations legislation and issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in H.R.__, FY17 Agriculture Appropriations legislation.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · fourth_quarter · 4A
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430,Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to tobacco control related appropriated accounts, including CDC's Office of Smoking & Health in H.R.2029, Omnibus Appropriations legislation.
Issues relating to the tax treatment of nonprofits, charitable IRA rollover within tax extenders legislative proposals, including governance of nonprofit organizations.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · fourth_quarter · Q4
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; S.1558, Department of Defense Appropriations Act; and H.R.2029, Mil-Con Veterans Affairs (Omnibus) Appropriations Act.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · third_quarter · Q3
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; legislation relating to trade promotion authority; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act.
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC via AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
2015 · second_quarter · Q2
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, product regulation, and smokefree environments, including: (1) implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations: (2) cessation and prevention programs authorized as part of P.L. 111-148, the Patient Protection & Affordable Care Act of 2010; (3) Framework Convention on Tobacco Control (FCTC) and tobacco tax proposals contained in the President's FY16 Budget. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; legislation relating to trade promotion authority; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid. Issues relating to inclusion of palliative care as a bundled service within CMS quality based payment programs and H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; H.R.2810 & H.R.2, the Medicare Access and CHIP Reauthorization Act of 2015 and issues within related to Federally Qualified Health Centers; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID-19 Act S.2622, The Quit Because of COVID-19 Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The PROTECT Act
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: The Build Back Better Act, HR 5376 & budget reconciliation discussions HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) HR 526, the Ensuring Coverage in Public Health Emergencies Act S 779, the Protecting Americans with Pre-existing Conditions Act S 1556, the No Junk Plan Act HR 1790, the Fair Indexing for Health Care Affordability Act HR 1796, the Health Care Enrollment Innovation Fund HR 1872, the Marketing and Outreach Restoration to Empower Health Education Act HR 1875, to eliminate the short-term limited duration insurance exemption with respect to individual health insurance coverage HR 1878, the State Health Care Premium Reduction Act HR 1890, the Health Care Consumer Protection Act Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0
FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. HR 1319, American Rescue Plan Act of 2021
Taxation/Internal Revenue Code Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to economic relief for nonprofit organizations and charitable giving incentives included in H.R. 6408, the Saving the Organizations that Serve (SOS) America Act, H.R.3814, the Reviving the Economy Sustainably Towards A Recovery in Twenty-twenty Act or the RESTART Act, S.3747, the WORK NOW Act, S.4032 and H.R.7324, the Universal Giving Pandemic Response Act, charitable giving amendment (S.Amdt. 1566) to the CARES Act, S.4001and S.4209, the Protecting Nonprofits from Catastrophic Cash Flow Strain Act of 2020, H.R. 7066, the Reopening America by Supporting Workers and Businesses Act of 2020, the Help Charities Protect Communities Act (introduction pending), S. 178 (legislative vehicle for the Protect Act), and HR 925, The Heroes Act. Medical expense deduction - lowering the percentage to 7.5%
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020 The Access to Genetic Counselor Services Act of 2019, HR 3235 Advocacy w. CMS related to state Medicaid 1115 waiver approvals Multi-Cancer Early Detection Screening Coverage Act of 2020, HR 8845
FY 2021 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding of the World Health Organization and for cervical cancer screening & treatment and HPV vaccination; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 133, Consolidated Appropriations Act, 2021 HR 8337, Making continuing appropriations for fiscal year 2021, and for other purposes HR 925, the HEROES Act HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act H.R.7610, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 S 178, Legislative vehicle for the Protect Act
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; H.R, 7286 and S 4524, the Quit Because of COVID-19 Act:
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; H.R, 7286 and S 4524, the Quit Because of COVID-19 Act:
FY 2021 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding of the World Health Organization and for cervical cancer screening & treatment and HPV vaccination; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 133, Consolidated Appropriations Act, 2021 HR 8337, Making continuing appropriations for fiscal year 2021, and for other purposes HR 925, the HEROES Act HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act H.R.7610, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 S 178, Legislative vehicle for the Protect Act
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020 The Access to Genetic Counselor Services Act of 2019, HR 3235 Advocacy w. CMS related to state Medicaid 1115 waiver approvals Multi-Cancer Early Detection Screening Coverage Act of 2020, HR 8845
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 6514, Worker Health Coverage Protection Act HR 1425, Patient Protection and Affordable Care Enhancement Act Issues related to regulations for implementing section 1557 of the Affordable Care Act on anti-discrimination HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act Issues related to the Senate HELP Committee initiative on preparing for future pandemics. Regulatory issues related to telehealth Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Introduction of the S. 3404 & H.R. 6102, Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing health disparities in cancer clinical trials; Issues related to capturing racial and ethnic data demographic data for communities disproportionately affected by coronavirus; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 S. 2497, the Dependent Income Exclusion Act; Issues related to HHS regulation of prescription drug prices and costs; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; H.R. 6556, the Gabriella Miller Kids First Research Act 2.0; H.R. 4439 & S. 4010, the Creating Hope Reauthorization Act; H.R.6666 & S. 4315, the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act, bill related to support needed data collection efforts to begin to contain coronavirus; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; Issues related to improving data collection during the COVID-19 pandemic; and H.Res 1125, which expresses support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics in clinical trials for therapies, diagnostics, and vaccines for COVID -19. S 4557, COVID Enrollment Response Act (Sen. Baldwin)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020 The Access to Genetic Counselor Services Act of 2019, HR 3235 Advocacy w. CMS related to state Medicaid 1115 waiver approvals Multi-Cancer Early Detection Screening Coverage Act of 2020, HR 8845
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 6514, Worker Health Coverage Protection Act HR 1425, Patient Protection and Affordable Care Enhancement Act Issues related to regulations for implementing section 1557 of the Affordable Care Act on anti-discrimination HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act Issues related to the Senate HELP Committee initiative on preparing for future pandemics. Regulatory issues related to telehealth Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Introduction of the S. 3404 & H.R. 6102, Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing health disparities in cancer clinical trials; Issues related to capturing racial and ethnic data demographic data for communities disproportionately affected by coronavirus; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 S. 2497, the Dependent Income Exclusion Act; Issues related to HHS regulation of prescription drug prices and costs; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; H.R. 6556, the Gabriella Miller Kids First Research Act 2.0; H.R. 4439 & S. 4010, the Creating Hope Reauthorization Act; H.R.6666 & S. 4315, the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act, bill related to support needed data collection efforts to begin to contain coronavirus; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; Issues related to improving data collection during the COVID-19 pandemic; and H.Res 1125, which expresses support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics in clinical trials for therapies, diagnostics, and vaccines for COVID -19. S 4557, COVID Enrollment Response Act (Sen. Baldwin)
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to economic relief for nonprofit organizations and charitable giving incentives included in H.R. 6408, the Saving the Organizations that Serve (SOS) America Act, H.R.3814, the Reviving the Economy Sustainably Towards A Recovery in Twenty-twenty Act or the RESTART Act, S.3747, the WORK NOW Act, S.4032 and H.R.7324, the Universal Giving Pandemic Response Act, charitable giving amendment (S.Amdt. 1566) to the CARES Act, S.4001and S.4209, the Protecting Nonprofits from Catastrophic Cash Flow Strain Act of 2020, H.R. 7066, the Reopening America by Supporting Workers and Businesses Act of 2020, the Help Charities Protect Communities Act (introduction pending), S. 178 (legislative vehicle for the Protect Act), and HR 925, The Heroes Act. Medical expense deduction - lowering the percentage to 7.5%
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; H.R, 7286 and S 4524, the Quit Because of COVID-19 Act:
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
FY 2021 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding of the World Health Organization and for cervical cancer screening & treatment and HPV vaccination; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 8337, Making continuing appropriations for fiscal year 2021, and for other purposes HR 925, the HEROES Act HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act H.R.7610, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 S 178, Legislative vehicle for the Protect Act
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; H.R, 7286 and S 4524, the Quit Because of COVID-19 Act:
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to economic relief for nonprofit organizations and charitable giving incentives included in H.R. 6408, the Saving the Organizations that Serve (SOS) America Act, H.R.3814, the Reviving the Economy Sustainably Towards A Recovery in Twenty-twenty Act or the RESTART Act, S.3747, the WORK NOW Act, S.4032 and H.R.7324, the Universal Giving Pandemic Response Act, charitable giving amendment (S.Amdt. 1566) to the CARES Act, S.4001and S.4209, the Protecting Nonprofits from Catastrophic Cash Flow Strain Act of 2020, H.R. 7066, the Reopening America by Supporting Workers and Businesses Act of 2020, the Help Charities Protect Communities Act (introduction pending), S. 178 (legislative vehicle for the Protect Act), and HR 925, The Heroes Act. Regulations on health care sharing ministries and direct primary care arrangements
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 1948, Lymphedema Treatment Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Senate introduction (no bill number just yet); Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement. HR 2477, Beneficiary Enrollment Notification and Eligibility Simplification Act (BENES) Regulatory issues related to Medicaid and value-based payment HR 7663, Protecting Access to Post COVID 19 Telehealth Act of 2020
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; H.R, 7286, the Quit Because of COVID-19 Act
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 6514, Worker Health Coverage Protection Act HR 1425, Patient Protection and Affordable Care Enhancement Act Issues related to regulations for implementing section 1557 of the Affordable Care Act on anti-discrimination HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act Issues related to the Senate HELP Committee initiative on preparing for future pandemics. Regulatory issues related to telehealth Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Introduction of the S. 3404 & H.R. 6102, Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing health disparities in cancer clinical trials; Issues related to capturing racial and ethnic data demographic data for communities disproportionately affected by coronavirus; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 S. 2497, the Dependent Income Exclusion Act; Issues related to HHS regulation of prescription drug prices; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; H.R. 6556, the Gabriella Miller Kids First Research Act 2.0; H.R. 4439 & S. 4010, the Creating Hope Reauthorization Act; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or The HEROES Act HR 3436, Chronic Care Management Improvement Act HR 1948, Lymphedema Treatment Act; HR 6808, Patient Navigation Assistance Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trials; Issues related to Medicaid Non-Emergency Medical Transportation; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement.
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to economic relief for nonprofit organizations and charitable giving incentives included in H.R. 6408, the Saving the Organizations that Serve (SOS) America Act, H.R.3814, the Reviving the Economy Sustainably Towards A Recovery in Twenty-twenty Act or the RESTART Act, S.3747, the WORK NOW Act, S.4032 and H.R.7324, the Universal Giving Pandemic Response Act, charitable giving amendment (S.Amdt. 1566) to the CARES Act, S.4001and S.4209, the Protecting Nonprofits from Catastrophic Cash Flow Strain Act of 2020, H.R. 7066, the Reopening America by Supporting Workers and Businesses Act of 2020, the Help Charities Protect Communities Act (introduction pending)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
FY 2021 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding for cervical cancer screening & treatment and HPV vaccination; and issues related to highway authorization and appropriations. HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 6201, Families First Coronavirus Response Act (Medicaid and Medicare provisions) HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Medicaid and Medicare provisions) H.R. 748 Coronavirus Aid, Relief, and Economic Security Act HR 1948, Lymphedema Treatment Act; HR 6808, Patient Navigation Assistance Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; CMS-issued regulations pertaining to Medicare Part B reimbursement - the CY2020 Medicare Physician Fee Schedule; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; The Healthy Adult Opportunity guidance from CMS on allowing states to block grant their Medicaid programs Issues related to Medicaid Non-Emergency Medical Transportation; and S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year; and Issues related to Chimeric antigen receptor (CAR) T-cell therapy and reimbursement.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 6201, Families First Coronavirus Response Act HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Introduction of the S. 3404 & H.R. 6102, Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 S. 2497, the Dependent Income Exclusion Act; Issues related to HHS regulation of prescription drug prices; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; and S. 1608, the Promoting Physical Activity for Americans Act.
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, issues regarding the medical expense deduction, and issues regarding economic relief for nonprofit organizations. HR 6704, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 HR 748, Coronavirus Aid, Relief, and Economic Security Act Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to the medical expense deduction and unrelated business income taxation (UBIT) in H.R. 1865, Further Consolidated Appropriations Act, 2020. Issues related to economic relief for nonprofit organizations and charitable giving incentives included in H.R. 6408, the Saving the Organizations that Serve (SOS) America Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
FY 2020 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; issues related to global health funding for cervical cancer screening & treatment and HPV vaccination; and issues related to highway authorization and appropriations.
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues respecting the medical expense deduction. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act. Issues related to the medical expense deduction and unrelated business income taxation (UBIT) in H.R. 1865, Further Consolidated Appropriations Act, 2020.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1948, Lymphedema Treatment Act; HR 6808, Patient Navigation Assistance Act; HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; S.2218 and H.R 4821, the Covering Our FAS Allies (COFA) Act & issues related to Medicaid coverage for Compacts of Free Association (COFA) migrants; CMS-issued regulations pertaining to Medicare Part B reimbursement - the CY2020 Medicare Physician Fee Schedule; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; Issues related to potential Administration guidance relating to giving states the option to block grant their Medicaid program; Issues related to Puerto Ricos Medicaid program, including H.R. 3631, Territories Health Care Improvement Act; H.R. 3, the Lower Drug Prices Now Act - legislation for lowering prescription drug costs, lowering out of pocket expenses for Medicare beneficiaries, and placing a cap on Medicare Part D; S. 2543, the Prescription Drug Pricing Reduction Act of 2019 - legislation for lowering prescription drug costs, lowering out of pocket costs for Medicare beneficiaries, and placing a cap on Medicare Part D; Issues related to Medicaid Non-Emergency Medical Transportation; and S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Issues relating to FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 HR___, Medical Records Fairness Act (Rep. Bill Foster, D-IL); S. 2497, the Dependent Income Exclusion Act; SJ Res 52, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; Issues related to prescription drug costs - H.R. 3, the Lower Prescription Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act of 2019; Issues related to HHS regulation of prescription drug prices; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; S. 2546 & H.R. 2279, the Safe Step Act of 2019 - amends the Employee Retirement Income Security Act (ERISA) to require group health plans to provide an exception process for any medication step therapy protocol, tools used by health plans to control spending on patients medications, to help ensure patients are able to safely and efficiently access treatment; S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; S. 1608, the Promoting Physical Activity for Americans Act; and Issues related to the nomination of Dr. Stephen Hahn to be Commissioner of the Food and Drug Administration.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues respecting the medical expense deduction. Issues related to charitable IRA rollovers, including H.R. 3832 and S. 1257, the Legacy IRA Act.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 3835, the Cancer Care Planning and Communications Act; CMS-issued regulations pertaining to Medicare Part B reimbursement - the CY2020 Medicare Physician Fee Schedule; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; Issues related to potential Administration guidance relating to giving states the option to block grant their Medicaid program; Issues related to Puerto Ricos Medicaid program, including H.R. 3631, Territories Health Care Improvement Act; H.R. 3, the Lower Drug Prices Now Act - legislation for lowering prescription drug costs, lowering out of pocket expenses for Medicare beneficiaries, and placing a cap on Medicare Part D; S. 2543, the Prescription Drug Pricing Reduction Act of 2019 - legislation for lowering prescription drug costs, lowering out of pocket costs for Medicare beneficiaries, and placing a cap on Medicare Part D; and Issues related to Medicaid Non-Emergency Medical Transportation.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; S. 655 and H.R.1498, Stopping Appealing Flavors in E-Cigarettes for Kids Act; S. 1048 and H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction Act; H.R.1854 & S.9, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 2084, the Stopping Consumption of Tobacco by Teens Act of 2019; H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019; S. 1258 and H.R. 2411, Tobacco to 21 Act; Issues related to FDA tobacco control to be considered in House and Senate in the FY20 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation; H.R. 293, Youth Vaping Prevention Act of 2019; S. 616, E-Cigarette youth Protection Act; S. 1253, Preventing Online Sales of E-Cigarettes to Children Act; S. 1541, Tobacco-Free Youth Act; S. 1895, Lower Health Care Costs Act regarding tobacco 21 age of sale provisions; S 1832, Smoke-Free Schools Act; S. 2726, Banning Smoking on Amtrak Act of 2019; and Issues related to smoke-free policies for the Veterans Health Administration, H.R. 3700 and S. 2106. Issues related to electronic cigarettes: H.R. 4249, Stop Vaping Ads Act; S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act; H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019; and S. 2519, Ending New Nicotine Dependencies Act of 2019 (ENND Act). Issues related to taxation of tobacco products: and S. 2463, E-cigarette Tax Parity Act; S. 2517, Tobacco Tax Equity Act of 2019.
FY 2020 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for cancer programs within the CDMRP; funding for development of nuclear isotopes for medical diagnostic technology; issues related to global health funding for cervical cancer screening & treatment and HPV vaccination; and and issues related to highway authorization and appropriations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
FY 2020 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; funding for development of nuclear isotopes for medical diagnostic technology; and issues related to global health funding for cervical cancer screening & treatment and HPV vaccination.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1010, to provide that the short-term rule has no force or effect; HR 986 & S 466, Protecting Americans with Pre-Existing Conditions Act; HR 1425, State Health Care Premium Reduction Act; HR 1386, Expand Navigators Resources for Outreach, Learning, and Longevity Act of 2019; HR 1884, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act of 2019; HR 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019; HR 1868, the Health Care Affordability Act, to expand subsidies in the ACA individual marketplace HR 1870, the Family Health Care Affordability Act, to fix the family glitch S 1935, the Family Coverage Act, to fix the family glitch Issues related to surprise billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Issues related to Breast Density and Mammography Reporting; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Issues relating to FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 1948 & S. 518, the Lymphedema Treatment Act H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; and Cannabis research issues, including S. 2032.
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; HR 3107, Improving Seniors Timely Access to Care Act of 2019, on prior authorization in the Medicare Advantage Program CMS-issued regulations pertaining to Medicare Part B reimbursement; HR 913, The CLINICAL TREATMENT Act, Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; Issues related to potential Administration guidance relating to giving states the option to block grant their Medicaid program; Issues related to Puerto Ricos Medicaid program, including H.R. 3631, Territories Health Care Improvement Act. Issues related to utilization management in Medicare Part D plans; issues related to the Medicare Part D caps Potential legislation for lowering prescription drug costs and lowering out of pocket costs for Medicare beneficiaries; and CMS proposed regulatory changes on the six protected classes policy within the Medicare Part D prescription drug benefit.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1570 and S. 668, the Removing Barriers to Colorectal Cancer Screening Act, and regulatory issues related to the Medicare coinsurance issue in these bills; States Achieve Medicaid Expansion (SAME) Act, S. 585, to ensure states receive the same matching funds regardless of when they expand their Medicaid program; Lymphedema Treatment Act, HR 1948, on Medicare reimbursement for supplies needed by lymphedema patients; CMS-issued regulations pertaining to Medicare Part B reimbursement; Draft legislation on establishment of Medicaid reimbursement for patient navigation; Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial; Issues related to Medicare coverage for BCRA testing and preventive surgery; Issues related to utilization management in Medicare Part D plans; Potential legislation for lowering prescription drug costs and lowering out of pocket costs for Medicare beneficiaries; and CMS proposed regulatory changes on the six protected classes policy within the Medicare Part D prescription drug benefit.
FY 2019 and FY 2020 federal appropriations for: The Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the State/Foreign Operations Appropriations Act; issues relating to global health funding for HPV vaccination and cervical cancer screening and treatment; and, issues regarding future work and funding of the CDC tobacco work. FY 2020 federal appropriations for: cancer research and prevention funding at the NIH, NCI and CDC.
Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of electronic cigarettes and cigars; H.R.1854 & S.9, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 2084, the Stopping Consumption of Tobacco by Teens Act of 2019; H.R. 2111 and S. 1048, The Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act, and issues regarding age of sale of tobacco products; Issues related to FDA tobacco control to be considered in House and Senate in the FY20 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation; Issues related to tobacco taxes, flavored tobacco products, and online sale of tobacco products, H.R. 293, Youth Vaping Prevention Act of 2019; and Issues related to smoke-free policies for the Veterans Health Administration.
Issues regarding expanding the availability of the charitable deduction for non-itemizers and issues respecting charitable giving and life income planning and issues respecting the medical expense deduction.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control as considered in House and Senate, FY18 and The FY19 Agriculture Appropriations legislation and CDC tobacco activities as considered in the Labor, Health and Human Services Appropriations legislation. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273. Issues regarding flavors in tobacco products including e-cigarettes and cigars respecting S.3319, the SAFE Kids Act, and development of similar legislation. Issues relating to trade and investment agreements and tobacco. Issues regarding CDC future funding and work related to tobacco.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479 and regulatory issues related to the Medicare coinsurance issue in these bills; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation. Issues relating to Medicaid covering routine care costs for beneficiaries who participate in an approved clinical trial. Issues related to Medicare coverage for BCRA testing and preventive surgery (proposed Murkowski legislation).
Expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988, S. 2123 and H.R. 5771, The Charitable Giving Tax Deduction Act. H.R. 1337, Legacy IRA Act respecting charitable giving and life income planning, and H.R. 6760, the Protecting Family and Small Business Tax Cuts Act of 2018 respecting the medical expense deduction
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988, S. 2123 and H.R. 5771, The Charitable Giving Tax Deduction Act. H.R. 1337, Legacy IRA Act respecting charitable giving and life income planning, and H.R. 6760, the Protecting Family and Small Business Tax Cuts Act of 2018 respecting the medical expense deduction
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation.
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; H.R. 4122 & S. 2006, the Breast Density & Mammography Reporting Act; H.R.820 & S.292, the Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, issues related to reform of laboratory and diagnostic tests and the development of a new discussion draft for the Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. The proposed Medical Records Fairness Act (no number yet). Issues regarding the Affordable Care Act premium tax credits and catastrophic plans, HR 6311. Issues regarding protections for people with pre-existing conditions, including S. 3388, HR 6898, and H. Res. 1066. Resolutions to disapprove the short-term rule, H.J. Res 140 and S. J. Res. 63. Advocacy against including the Association Health Plan provision of the House Farm bill in the conference report, H.R. 2 and s. 3042 (section 6004 of the House-passed version of the legislation). Issues involving patient navigation, including the Patient Navigation Assistance Act, HR 6808. H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on patient access to medical records. Draft legislation on FDA regulation of laboratory tests. H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018. Issues related to caregiving, including H.R. 3759/S. 1028, the RAISE Family Caregivers Act.
Federal budget and appropriations for cancer research and programs, including: H.R. 6157, the Defense and Labor, HHS, Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 respecting FY 2019 federal appropriations for NIH, NCI, and CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act, and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act;; and issues relating to global health funding for HPV vaccination and cervical cancer screening and treatment.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and, S. 2123. and H.R. 5771, The Charitable Giving Tax Deduction Act. H.R. 1337, Legacy IRA Act respecting charitable giving and life income planning.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 and FY19 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.HR 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, respecting Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, and protecting communities. Draft legislation on establishment of Medicaid payment for patient navigation.
Federal budget and appropriations for cancer research and programs, including: HR 1625, The Consolidated Approp. Act of 2018 respecting FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Creating parity in taxation of tobacco products respecting S. 1837; HR1 tax bill relating to its implementation roll out and impact on charitable deductions.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations, and H.R. 2194 Cigarette Smoking Reduction and Electronic Vapor Alternatives Act of 2017. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.
HR1 tax bill, issues relating to the tax treatment of nonprofits, including charitable deductions, elimination of the individual fee for the Affordable Care Act, deduction of health care costs by individual tax payers, and availability of the Orphan Drug Tax Credit. Also expanding the availability of the charitable deduction for non-itemizers respecting H.R. 3988 and S. 2123. Also, creating parity in taxation of tobacco products respecting S. 1837
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act. Also, issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Federal budget and appropriations for cancer research and programs, including: FY 2017 and FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act. Also, issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including: FY 2017 and FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act. Also, issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; and, H.R.820 & S.292, Childhood Cancer STAR Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on issues relating to NIH and cancer moonshot funding in the context of H.R. 2028, the Continuing and Security Assistance Appropriations Act; and, H.R. 34, the 21st Century Cures Act. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including certain votes on issues relating to NIH and cancer moonshot funding in the context of H.R. 2028, the Continuing and Security Assistance Appropriations Act; and, H.R. 34, the 21st Century Cures Act. Also issues relating to non-communicable diseases with respect to S.3117, the State/Foreign Operations FY17 Appropriations legislation, the House companion draft Appropriations bill, and the Continuing Resolution for FY17 enacted prior to October 1, 2016.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opioid prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments, S.3077, the Marijuana Effective Drug Studies Act of 2016.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement.
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430, Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to FDA tobacco control, as considered in House and Senate, FY17 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119 & S.2748, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; H.R.3381 & S.1883, Childhood Cancer STAR Act; and regulations relating to tanning beds. In addition, regulatory issues before the FDA relating to laboratory developed tests, and any legislation pertaining thereto, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act, CDC opioid prescription guidelines, and legislation relating to opiod prescribing, addition and rehabilitation; H.R.5475, the Health Equity and Accountability Act; S.2787, the SAME Act and Senate Amendment 4369 to S.2943, the Senate Defense Authorization bill; and S.3136, H.R.5003 childhood nutrition bill; and H.R.2017 and S.2217, the Common Sense Nutrition Disclosure Act; and S.524 and H.R.953, the Comprehensive Addiction and Recovery Act, and related bills and amendments.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Federal budget and appropriations for cancer research and programs, including: federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; and programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H. Con. Res. 25, the FY17 budget resolution, H.R.__, the FY17 Agriculture Appropriations legislation and issues relating to NIH funding in the context of the Senate HELP Committee Medical Innovation legislation.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Issues relating to the tax treatment of nonprofits, including governance of nonprofit organizations.
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act; and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, H.R.644 - America Gives More Act; and CDC opioid prescription guidelines.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; S.1558, Department of Defense Appropriations Act; and H.R.2029, Mil-Con Veterans Affairs (Omnibus) Appropriations Act.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues before CMS relating to: Medicare payment for preventive screening; coordinated patient care; care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, product regulation, and smokefree environments, including implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to tobacco and trade, including: the Trans-Pacific Partnership and Transatlantic Trade and Investment Partnership; proposed FDA regulation of electronic cigarettes and/or cigars; H.R.478/S.430,Protecting Children from Electronic Cigarette Advertising Act; H.R.3042, Stop Tobacco Sales to Youth Act; S.450, Tobacco Tax Equity Act; H.R.1749, STOP Act; and S.1129, Tobacco Tax and Enforcement Reform Act. Issues related to tobacco control related appropriated accounts, including CDC's Office of Smoking & Health in H.R.2029, Omnibus Appropriations legislation.
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues before CMS relating to: Medicare payment for preventive screening; coordinated patient care; care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act of 2015; and H.R.1190, Protecting Seniors' Access to Medicare Act.
Issues relating to the tax treatment of nonprofits, charitable IRA rollover within tax extenders legislative proposals, including governance of nonprofit organizations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; and S.1558, Department of Defense Appropriations Act.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations within tax extenders legislative proposals, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY16 Budget.
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.3119, the Palliative Care and Hospice Education and Training Act; H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, suncreens, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act; an issues before the CDC, including opioid prescription guidelines.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including follow-on legislation to H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 (IH) & S.641, the Palliative Care and Hospice Education and Training Act (113th Congress), H.R.716 & S.370, the Breast Density & Mammography Reporting Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, H.R.2739/S.1566 - the Cancer Drug Coverage Parity Act, H.R.2846 - Planning Actively for Cancer Treatment Act, S.1014 - Personal Care Products Safety Act, H.R.1608 - Lymphedema Treatment Act, H.R.2191/S.1170 - the Breast Cancer Research Stamp Reauthorization Act, S.705 - Transportation Alternatives Act, S.540 - School Food Modernization Act, and H.R.644 - America Gives More Act.
Issues relating to the tax treatment of nonprofits, deductability of charitable donations within tax extenders legislative proposals, including governance of nonprofit organizations. Includes taxpayer deductibility and tobacco tax provisions in the President's FY16 Budget.
Federal budget and appropriations for cancer research and programs, including federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund; the Affordable Care Act provisions; programs for breast and cervical cancer, colorectal cancer, tobacco regulation and cessation, patient navigators, patient quality of life, global health, and other appropriated accounts relating to cancer, including H.Con.Res.27 & S.Con.Res.11, FY16 proposed budget resolutions; H.R.6, the 21st Century Cures Act; H.R.3020/S.1695, Departments of Labor HHS Appropriations legislation for FY16; H.R.2772, S.1725, Department of State, Foreign Operations Appropriations for FY16; and S.1558S, Department of Defense Appropriations Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office